We similarly found an expansion of circulating fibrocytes in patients with pneumonia and ARDS, which disproportionately expressed myofibroblast markers and expressed phosphorylated SMAD-2/3, evidence of TGF-β receptor signaling. The gene discussed is SMAD2; the disease is pneumonia.